Sequential versus concurrent use of chemotherapy and endocrine therapy in the adjuvant treatment of ER-positive breast cancer: A systematic review and Bayesian network meta-analysis.
Tianfu Li(Jinling Institute of Technology), Ying Lin(Sun Yat-sen University), Zhen Shan(Shenyang Medical College), Qi Zhang, Liang Yu(Sun Yat-sen University), Deyuan Zhang(Anhui Medical University), Xiaying Kuang(Sun Yat-sen University), Si-Hong Lu(Sun Yat-sen University), Nan Shao(The First People's Hospital of Changzhou)
Cited by 1
Related Papers
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
|Nature Communications|2021|358
Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
|Cancer Cell International|2020|136
An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells
|Journal of the American College of Cardiology|2015|126